Filtros de búsqueda

Lista de obras de

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa

artículo científico publicado en 2015

A high HIV DNA level in PBMCs at antiretroviral treatment interruption predicts a shorter time to treatment resumption, independently of the CD4 nadir ⬇️

artículo científico publicado el 1 de noviembre de 2010

A highly virulent variant of HIV-1 circulating in the Netherlands

artículo científico publicado en 2022

A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control

artículo científico publicado en 2015

A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis

scientific article published on 01 January 2007

A novel hepatitis B virus mutation with resistance to adefovir but not to tenofovir in an HIV-hepatitis B virus-co-infected patient.

artículo científico publicado en 2006

A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposity

artículo científico publicado en 2012

A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients.

artículo científico publicado en 2009

Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine

artículo científico publicado en 2008

Absence of a relationship between antibodies to hepatitis C virus and hepatocellular carcinoma in Mozambique

artículo científico publicado en 1993

Acute coronary syndrome in human immunodeficiency virus-infected patients: characteristics and 1 year prognosis

artículo científico publicado en 2010

Acute hepatic cytolysis in an HIV-infected patient taking atazanavir

artículo científico publicado en 2004

An improved understanding of severe liver morbidity in HIV-infected individuals

artículo científico publicado en 2016

Antiretroviral therapy in resource-poor countries: illusions and realities

article published in 2005

Aortic stiffness aging is influenced by past profound immunodeficiency in HIV-infected individuals: results from the EVAS-HIV (EValuation of Aortic Stiffness in HIV-infected individuals).

artículo científico publicado en 2016

Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir

artículo científico publicado en 2020

Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection

artículo científico publicado en 2014

Atazanavir urinary stones in an HIV-infected patient

scientific article published on 01 October 2006

Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial

artículo científico publicado en 2017

Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneumoniae

artículo científico publicado en 2018

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

artículo científico publicado en 2015

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, o

artículo científico publicado en 2017

Brief Report: Impact of ART Classes on the Increasing Risk of Cerebral Small-Vessel Disease in Middle-Aged, Well-Controlled, cART-Treated, HIV-Infected Individuals

artículo científico publicado en 2019

Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study

artículo científico publicado en 2015

CD4 T-Cell Responses in Primary HIV Infection: Interrelationship with Immune Activation and Virus Burden

artículo científico publicado en 2016

Campylobacter bacteremia: clinical features and factors associated with fatal outcome.

artículo científico publicado en 2008

Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?

artículo científico publicado en 2013

Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).

artículo científico publicado en 2010

Chlamydia trachomatis screening in urine among asymptomatic men attending an STI clinic in Paris: a cross-sectional study

artículo científico publicado en 2019

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial

artículo científico publicado en 2013

Combining the Estimated Date of HIV Infection with a Phylogenetic Cluster Study to Better Understand HIV Spread: Application in a Paris Neighbourhood

artículo científico publicado en 2015

Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.

artículo científico publicado en 2011

Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patients

artículo científico publicado en 2008

Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.

artículo científico publicado en 2008

Compromised immunologic recovery in patients receiving tipranavir/ritonavir coadministered with tenofovir and didanosine in Randomized Evaluation of Strategic Intervention in multidrug-resiStant patients with tipranavir (RESIST) studies

artículo científico publicado en 2007

Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial

artículo científico publicado en 2012

Correction: Absence of peripapillary retinal nerve-fiber-layer thinning in combined antiretroviral therapy-treated, well-sustained aviremic persons living with HIV

artículo científico publicado en 2020

Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessment

article

Correlation of serum hepatitis B core-related antigen with HBV total intrahepatic DNA and ccc-DNA viral load in HIV-hepatitis B coinfection

artículo científico publicado en 2020

Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)

scientific article published on 01 December 2019

Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors

scientific article published on 01 April 2006

Current state of and needs for hepatitis B screening: results of a large screening study in a low-prevalent, metropolitan region

artículo científico publicado en 2014

Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study

artículo científico publicado en 2019

Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients

artículo científico publicado en 2016

Determinants of adherence to non-occupational post HIV exposure prophylaxis

scientific article published on 01 January 2006

Development of anti-hepatitis B surface (HBs) antibodies after HBs antigen loss in HIV-hepatitis B virus co-infected patients

artículo científico publicado en 2017

Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study

scientific article published on 01 April 2019

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-in

artículo científico publicado en 2018

Drug use and HIV in West Africa: a neglected epidemic

artículo científico publicado en 2011

Drug-resistant and immune-escape HBV mutants in HIV-infected hosts.

artículo científico publicado en 2010

Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE):

article

Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials

scientific article published on 01 March 2020

ESBL-Producing Strain of Hypervirulent Klebsiella pneumoniae K2, France

artículo científico publicado en 2016

Early Plasmacytoid Dendritic Cell Changes Predict Plasma HIV Load Rebound during Primary Infection

artículo científico publicado en 2004

Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer

article

Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV

article

Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients

artículo científico publicado en 2013

Effectiveness of hepatitis B rapid tests toward linkage-to-care: results of a randomized, multicenter study

artículo científico publicado en 2016

Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, ra

artículo científico publicado en 2016

Efficacy and tolerance of telaprevir in HIV-hepatitis C virus genotype 1-coinfected patients failing previous antihepatitis C virus therapy: 24-week results

artículo científico publicado en 2013

Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials

artículo científico publicado en 2014

Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient

artículo científico publicado en 2009

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.

artículo científico publicado en 2010

Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies

artículo científico publicado en 2018

Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough

artículo científico publicado en 2004

Erratum to: Kinetics of Hepatitis B Core-Related Antigen and Anti-Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus-Hepatitis B Coinfection

artículo científico publicado en 2020

Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial

artículo científico publicado en 2013

Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients

artículo científico publicado en 2015

Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis.

artículo científico publicado en 2016

External Validation of Atazanavir/Ritonavir Genotypic Score in HIV-1 Protease Inhibitor-Experienced Patients

article

Factors Associated With Virological Failure in HIV-1–Infected Patients Receiving Darunavir/Ritonavir Monotherapy

article

Factors predictive of virological failure on atazanavir in 310 HIV-infected patients

artículo científico publicado en 2010

Failure of HIV-2 viral load assay in a severely immunodeficient patient: clinical and therapeutic management issues

scientific article published on 15 November 2005

Fanconi syndrome and renal failure induced by tenofovir: a first case report

artículo científico publicado en 2002

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial

artículo científico publicado en 2017

Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM

scientific article published on 19 April 2020

HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study

artículo científico publicado en 2017

HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis

article

HIV resistance testing and detected drug resistance in Europe

artículo científico publicado en 2015

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

artículo científico publicado en 2019

Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa

artículo científico publicado en 2015

Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection

artículo científico publicado en 2018

High incidence of treatment-induced and vaccine-escape hepatitis B virus mutants among human immunodeficiency virus/hepatitis B-infected patients

artículo científico publicado en 2013

High variability of plasma drug concentrations in dual protease inhibitor regimens

artículo científico publicado en 2003

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

article

Hyperviscosity syndrome in an HIV-1-positive patient

artículo científico publicado en 2004

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels

article

Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification

artículo científico publicado en 2015

Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).

artículo científico publicado en 2015

Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults

scientific article published on 01 November 2007

Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study

artículo científico publicado en 2008

Impact of chronic hepatitis C and/or D on liver fibrosis severity in patients co-infected with HIV and hepatitis B virus

artículo científico publicado en 2007

Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens.

artículo científico publicado en 2018

Impact of etravirine use on hospitalization rates among highly pre-treated failing HIV-1 infected individuals between 2005 and 2011.

artículo científico publicado en 2014

Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir.

artículo científico publicado en 2004

Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial

artículo científico publicado en 2010

Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA.

artículo científico publicado en 2015

Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection

artículo científico publicado en 2005

Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study

scientific article published on 07 October 2019

Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing

artículo científico publicado en 2015

In the shadow of HIV/AIDS: forgotten diseases in sub-Saharan Africa: global health issues and funding agency responsibilities

artículo científico publicado en 2012

Inappropriate claim of ‘failure of ritonavir-boosted lopinavir monotherapy in HIV’ in the Monotherapy Switzerland/Thailand (MOST) trial

article

Incidence of lipodystrophy and metabolic disorders in patients starting non-nucleoside reverse transcriptase inhibitors in Benin

artículo científico publicado en 2009

Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients

artículo científico publicado en 2015

Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study

artículo científico publicado en 2016

Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy

artículo científico publicado en 2013

Influence of liver fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic hepatitis B or C.

artículo científico publicado en 2009

Influence of pravastatin on carotid artery structure and function in dyslipidemic HIV-infected patients receiving antiretroviral therapy

article

Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus

artículo científico publicado en 2004

Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients

artículo científico publicado en 2004

Intermittent antiretroviral therapy in patients with controlled HIV infection

artículo científico publicado en 2007

Kinetics of hepatitis B core-related antigen and anti-hepatitis B core antibody and their association with serological response in HIV-hepatitis B co-infection

artículo científico publicado en 2020

Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients

artículo científico publicado en 2012

Lack of regression of anal squamous intraepithelial lesions despite immune restoration under cART.

artículo científico publicado en 2013

Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection

artículo científico publicado en 2012

Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term tenofovir disoproxil fumarate use.

artículo científico publicado en 2010

Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study

artículo científico publicado en 2017

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

artículo científico publicado en 2020

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

scientific article published on 01 December 2020

Long-term efficacy and safety of E/C/F/TDF vs EFV/FTC/TDF and ATV+RTV+FTC/TDF in HIV-1-infected treatment-naïve subjects ≥50 years

artículo científico publicado en 2014

Long-term efficacy and tolerance of efavirenz- and nevirapine-containing regimens in adult HIV type 1 Senegalese patients

artículo científico publicado en 2008

Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate

artículo científico publicado en 2005

Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03(A) adjuvant in HIV-1-infected adults

artículo científico publicado en 2013

Long‐term effectiveness and safety of didanosine combined with lamivudine and efavirenz or nevirapine in antiretroviral‐naive patients: a 9‐year cohort study in Senegal ⬇️

artículo científico publicado el 19 de noviembre de 2010

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

artículo científico publicado en 2008

Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial ⬇️

artículo científico publicado el 15 de septiembre de 2010

Low genetic barrier to large increases in HIV-1 cross-resistance to protease inhibitors during salvage therapy

scientific article published on 01 January 2006

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire

artículo científico publicado en 2015

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

artículo científico publicado en 2008

Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.

artículo científico publicado en 2006

Metabolic disorders and cardiovascular risk in treatment-naive HIV-infected patients of sub-saharan origin starting antiretrovirals: impact of westernized lifestyle

artículo científico publicado en 2015

Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients

artículo científico publicado en 2017

Molecular epidemiology of ESBL-producing and : establishing virulence clusters

scholarly article by Laure Surgers et al published 2019 in Infection and Drug Resistance

Non-O:1 and non-O:139 Vibrio cholerae septicemia and pyomyositis in an immunodeficient traveler returning from Tunisia

artículo científico publicado en 2006

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal

artículo científico publicado en 2003

Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients.

artículo científico publicado en 2009

Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France

article

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

artículo científico

Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications

artículo científico publicado en 2014

Pharmacological data of a successful 4-days-a-week regimen in HIV antiretroviral therapy (ANRS 162-4D trial)

scientific article published on 03 October 2020

Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.

artículo científico publicado en 1996

Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells

artículo científico publicado en 2014

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

artículo científico publicado en 2002

Plasma HIV-RNA is the key determinant of long-term antibody persistence after Yellow fever immunization in a cohort of 364 HIV-infected patients

artículo científico publicado en 2012

Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption

artículo científico publicado en 2008

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal

artículo científico publicado en 2007

Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal

artículo científico publicado en 2007

Potential Role of Vδ2+ γδ T Cells in Regulation of Immune Activation in Primary HIV Infection

artículo científico publicado en 2017

Predictive values of the human immunodeficiency virus phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual-protease-inhibitor regimen

artículo científico publicado en 2008

Predictors of the virological response to a change in the antiretroviral treatment regimen in HIV-1-infected patients enrolled in a randomized trial comparing genotyping, phenotyping and standard of care (Narval trial, ANRS 088).

artículo científico publicado en 2003

Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study

artículo científico publicado en 2015

Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone

artículo científico publicado en 2009

Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.

artículo científico publicado en 2013

Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients

artículo científico publicado en 2010

Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus

artículo científico publicado en 2015

Recent HIV-1 infection contributes to the viral diffusion over the French territory with a recent increasing frequency

artículo científico publicado en 2012

Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study

artículo científico publicado en 2008

Relationship between regulatory T cells and immune activation in human immunodeficiency virus-infected patients interrupting antiretroviral therapy

artículo científico publicado en 2010

Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir

artículo científico publicado en 2007

Renal outcomes after up to 8 years of tenofovir exposure in HIV-HBV-coinfected patients

artículo científico publicado en 2016

Response to: 'Does the prevalence of radiographic hand osteoarthritis in patients with HIV-1 infection increase or not?' by Luo et al

artículo científico publicado en 2016

Risk factors for 'unmasking immune reconstitution inflammatory syndrome' presentation of tuberculosis following combination antiretroviral therapy initiation in HIV-infected patients

artículo científico publicado en 2010

Risk factors for CD4 lymphopenia in patients treated with a tenofovir/didanosine high dose-containing highly active antiretroviral therapy regimen

artículo científico publicado en 2005

Risk factors for acute liver enzyme abnormalities in HIV-hepatitis B virus-coinfected patients on antiretroviral therapy.

artículo científico publicado en 2007

Risk factors for raltegravir resistance development in clinical practice

article

Ritonavir associated maculopathy- multimodal imaging and electrophysiology findings

artículo científico publicado en 2020

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy

artículo científico publicado en 2015

Safety and Efficacy of Ombitasvir, Paritaprevir With Ritonavir ± Dasabuvir With or Without Ribavirin in Patients With Human Immunodeficiency Virus-1 and Hepatitis C Virus Genotype 1 or Genotype 4 Coinfection: TURQUOISE-I Part 2.

artículo científico publicado en 2017

Salvage therapy with amprenavir, lopinavir and ritonavir 200 mg/d or 400 mg/d in HIV-infected patients in virological failure.

artículo científico publicado en 2004

Salvage therapy with amprenavir, lopinavir and ritonavir is durably potent in HIV-infected patients in virological failure: 1-year results

artículo científico publicado en 2007

Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial.

artículo científico publicado en 2006

Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection

artículo científico publicado en 2017

Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated Adults

artículo científico publicado en 2019

Silent Cerebral Small-Vessel Disease Twice as Prevalent in Middle-Aged Well-Controlled cART-Treated HIV-Infected Individuals Than HIV-Uninfected Individuals

artículo científico publicado en 2017

Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage

artículo científico publicado en 2015

Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy

artículo científico publicado en 2016

Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives

artículo científico publicado en 2017

Subclinical cardiac abnormalities in human immunodeficiency virus-infected men receiving antiretroviral therapy

artículo científico publicado en 2008

Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data

artículo científico publicado en 2010

Sustained increase of HDL cholesterol over a 72-week period in HIV-infected patients exposed to an antiretroviral regimen including lopinavir/ritonavir

artículo científico publicado en 2008

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

artículo científico publicado en 2015

T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection

artículo científico publicado en 2014

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis

artículo científico publicado en 2014

Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study

artículo científico publicado en 2015

Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

artículo científico publicado en 2015

Testing for hepatitis B virus alone does not increase vaccine coverage in non-immunized persons

artículo científico publicado en 2017

The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.

artículo científico publicado en 2016

The PROTEA trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies/mL

artículo científico publicado en 2014

The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation

artículo científico publicado en 2013

The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study

artículo científico publicado en 2011

Time to end the ban on pregnancy and breastfeeding in antiretrovirals strategy trials

artículo científico publicado en 2013

Toward a global health approach: lessons from the HIV and Ebola epidemics

article

Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey

article

Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study

artículo científico publicado en 2013

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

artículo científico publicado en 2018

Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBV.

artículo científico publicado en 2014

Utility of HIV-1 DNA genotype in determining antiretroviral resistance in patients with low or undetectable HIV RNA viral loads

scientific article published on 01 November 2018

Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failures

artículo científico publicado en 2004

Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'Ivoire

artículo científico publicado en 2016

Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study).

artículo científico publicado en 2008

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues

artículo científico publicado en 2015

Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM)

artículo científico publicado en 2018

[HIV infection]

scientific article published on 01 September 2003

γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activation

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda